R&D Supercharging clinical development with RWE – with Recursion... Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
R&D Jennifer Schneider’s insights on immunotherapy at JP Morgan ... Jonah Comstock caught up with Jennifer Schneider, CEO of Centauri Therapeutics, in San Francisco in January during the JP Morgan Healthcare Conference
R&D JP Morgan Week 2025 – Ryan Spencer Join CEO Ryan Spencer of Dynavax Technologies in a video interview discussing JP Morgan Week 2025
News Gilead claims first FDA nod for a hepatitis D therapy At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
